RTNS 2012
Recent articles
Better tools needed to assess clinical trials
The past few years have seen an unprecedented number of clinical trials for experimental drugs to treat autism-related disorders, most notably for fragile X syndrome. But as the trials progress, scientists are calling for better methods to measure the drugs’ effectiveness.
Better tools needed to assess clinical trials
The past few years have seen an unprecedented number of clinical trials for experimental drugs to treat autism-related disorders, most notably for fragile X syndrome. But as the trials progress, scientists are calling for better methods to measure the drugs’ effectiveness.
Trials and tribulations
Clinical trials for fragile X drugs should include a behavioral therapy component, says a parent of a child with the disorder.
Trials and tribulations
Clinical trials for fragile X drugs should include a behavioral therapy component, says a parent of a child with the disorder.
Compensatory mechanisms
Identifying genetic and other factors that protect children at risk of autism from developing the disorder could provide new avenues for treatment.
Compensatory mechanisms
Identifying genetic and other factors that protect children at risk of autism from developing the disorder could provide new avenues for treatment.
Debate over quality of adult-derived stem cells rages on
As the use of induced pluripotent stem cells grows, researchers are searching for ways to make them behave more predictably.
Debate over quality of adult-derived stem cells rages on
As the use of induced pluripotent stem cells grows, researchers are searching for ways to make them behave more predictably.
Complex case
Multiple levels of complexity make it challenging to develop drugs to treat autism.
Complex case
Multiple levels of complexity make it challenging to develop drugs to treat autism.
Fast-forward
In the last three years, autism researchers have gone from sequencing single genes to whole exomes, as highlighted at the Translational Neuroscience Symposium in Switzerland last week.
Fast-forward
In the last three years, autism researchers have gone from sequencing single genes to whole exomes, as highlighted at the Translational Neuroscience Symposium in Switzerland last week.
Explore more from The Transmitter
Susana Carmona on the neurobiology of pregnancy
In a Q&A about her new book, “A Mother’s Brain,” Carmona shares key moments in her career that led her to study the neuroscience of motherhood and discusses some of the major questions the field still needs to address.
Susana Carmona on the neurobiology of pregnancy
In a Q&A about her new book, “A Mother’s Brain,” Carmona shares key moments in her career that led her to study the neuroscience of motherhood and discusses some of the major questions the field still needs to address.
Aging biomarkers in autism; and more
Here is a roundup of autism-related news and research spotted around the web for the week of 5 October.
Aging biomarkers in autism; and more
Here is a roundup of autism-related news and research spotted around the web for the week of 5 October.
Beyond wiring diagrams: Inside a $19 million effort to expand access to connectome technology
Davi Bock’s lab took the millions of images that led to the complete connectome of a fruit fly brain. Now he wants to apply “this high-throughput flashlight across all areas of biology.”
Beyond wiring diagrams: Inside a $19 million effort to expand access to connectome technology
Davi Bock’s lab took the millions of images that led to the complete connectome of a fruit fly brain. Now he wants to apply “this high-throughput flashlight across all areas of biology.”